Particle.news
Download on the App Store

AI Designs 16 New Bacteriophages, Raising Safety and Policy Questions

A lab demonstration shows AI can generate viable bacteriophage genomes with therapeutic promise for treating drug‑resistant infections.

Overview

  • The peer‑reviewed study published Thursday in Science reports researchers used genome‑language models to generate roughly 700,000 candidate sequences, synthesized about 300 designs, and validated 16 viable bacteriophages in the lab.
  • The engineered phages infect only bacteria, not humans, and the team excluded complex‑organism viruses from training data and worked in secure facilities to limit risk.
  • Laboratory tests found a cocktail of the AI‑designed phages could overcome resistance in some E. coli strains where comparable natural phage mixes failed, pointing to potential new treatments for antibiotic‑resistant infections.
  • Biosecurity experts including authors of a Science commentary warned the capability raises urgent biosafety and governance questions and urged tighter oversight of AI‑driven genome design.
  • U.S. guidance now restricts certain gain‑of‑function wet‑lab work but leaves many purely computational designs unregulated, and scientists note major technical hurdles remain to scale this method to larger, human‑infecting genomes.